For international patients, IVF treatment in the United States usually takes about 6 to 12 weeks from the first consultation to embryo transfer, but the amount of time you actually need to be physically in the U.S. can be much shorter. A typical travel plan may include one short visit for evaluation, sperm collection, egg retrieval, or embryo creation, followed by a later visit for frozen embryo transfer. Some patients coordinate much of the preparation from their home country and stay in the U.S. for only 10 to 20 days per treatment step, while others prefer to remain in the country for the entire stimulation and transfer cycle. The exact timeline depends on whether you are using your own eggs, donor eggs, donor sperm, a gestational carrier, preimplantation genetic testing, or a frozen embryo transfer plan.
Understanding the U.S. IVF Timeline for Travelers
Traveling to the United States for IVF is not simply a medical decision; it is also a scheduling, financial, emotional, and logistical project. Patients often ask one key question before they begin: “How long will I need to be away from home?” The answer is different for every family, but most U.S. fertility clinics follow a structured process that can be planned week by week. In broad terms, the IVF pathway includes the initial consultation, medical record review, diagnostic testing, treatment planning, ovarian stimulation, egg retrieval, fertilization, embryo culture, optional embryo biopsy for genetic testing, embryo freezing, uterine preparation, and embryo transfer.
For patients living in the U.S., these steps may feel spread out and manageable because clinic visits can be added to normal daily life. For travelers, every appointment matters. A blood test, ultrasound, medication teaching session, or consent-signing appointment can affect flights, hotel reservations, work leave, and the schedule of a partner or donor. This is why many U.S. clinics that frequently work with out-of-town or international patients design “travel-friendly IVF plans.” These plans attempt to complete as much early work as possible remotely, including video consultation, review of prior fertility records, genetic carrier screening coordination, infectious disease labs, semen analysis planning, and medication ordering.
In modern IVF, the most common timeline for traveling patients is not always a fresh transfer. Many clinics recommend a “freeze-all” cycle, meaning that embryos are created and frozen first, then transferred in a later cycle. This approach is especially common when patients choose preimplantation genetic testing for aneuploidy, often called PGT-A. Since PGT-A results can take one to three weeks depending on the laboratory and clinic workflow, the embryo transfer usually happens in a subsequent frozen embryo transfer cycle. For travelers, this can actually make planning easier because the stimulation and retrieval trip can be separated from the transfer trip.
However, not every patient needs or wants genetic testing. Some patients may proceed with a fresh embryo transfer approximately five days after egg retrieval, especially if they are younger, have a favorable prognosis, are not at high risk for ovarian hyperstimulation syndrome, and the physician believes the uterine environment is ready. A fresh-transfer trip often requires a longer continuous stay in the U.S., commonly around 16 to 22 days, because you must arrive before stimulation monitoring intensifies and remain through retrieval and transfer. A frozen-transfer plan may require one trip of about 10 to 14 days for retrieval and another trip of about 5 to 10 days for transfer, depending on how much monitoring is done locally before travel.
Quick Overview: How Long Does IVF in the U.S. Take?
| IVF Pathway | Total Calendar Time | Typical Time in the U.S. | Best Fit |
|---|---|---|---|
| Own eggs, fresh transfer | 4 to 7 weeks after testing is complete | About 16 to 22 days | Patients not doing PGT-A and medically suitable for fresh transfer |
| Own eggs, PGT-A, frozen transfer | 8 to 12+ weeks | Retrieval trip: 10 to 14 days; transfer trip: 5 to 10 days | Many traveling patients, especially when genetic testing is desired |
| Donor egg IVF | 6 to 12 weeks, sometimes longer if matching takes time | Often 5 to 10 days for embryo transfer; partner may travel earlier for sperm collection | Patients with low ovarian reserve, advanced maternal age, or prior poor egg quality |
| Embryo transfer only, embryos already created | 3 to 6 weeks | About 5 to 8 days | Patients with frozen embryos at a U.S. clinic or shipped embryos |
| IVF with gestational carrier | Several months, often 3 to 9+ months due to matching and legal steps | Varies; intended parents may travel for retrieval, sperm collection, or embryo creation | Patients who cannot safely carry a pregnancy or same-sex male couples |
These timeframes assume that the patient is medically ready to begin treatment and that there are no major delays related to abnormal test results, visa issues, donor matching, legal contracts, medication availability, or cycle scheduling. It is wise to build flexibility into your travel plan. Even in a well-organized IVF cycle, ovarian response can be faster or slower than expected, and the physician may move the trigger shot, egg retrieval, or transfer date by one or two days based on hormone levels and ultrasound findings.
Week 0 to Week 1: Choosing a Clinic and Scheduling the First Consultation
The first step is identifying a U.S. fertility clinic that is experienced with patients traveling from other states or other countries. This matters because a clinic that understands travel cases will often have a dedicated international patient coordinator, clear instructions for outside monitoring, telemedicine options, medication shipment support, and an established workflow for remote consent completion. When comparing clinics, patients should look beyond advertising claims and focus on physician experience, laboratory standards, communication style, embryo culture practices, PGT coordination, multilingual support if needed, and transparency about cost.
During this first week, most patients contact the clinic by email, website form, phone, or referral. The clinic may request basic information such as age, diagnosis, prior pregnancy history, menstrual cycle pattern, previous IVF outcomes, surgical history, current medications, and whether donor eggs, donor sperm, or a gestational carrier may be involved. If you already have fertility records, it is useful to send them before the consultation. Relevant records include AMH, FSH, estradiol, antral follicle count, semen analysis, hysterosalpingogram, saline sonogram, hysteroscopy records, prior stimulation protocols, egg retrieval reports, fertilization reports, embryo grading, PGT results, pregnancy outcomes, miscarriage testing, and any genetic carrier screening.
The initial consultation is often held by video, although some patients prefer to travel to the U.S. for an in-person visit. A remote consultation is usually sufficient for the first planning stage. The reproductive endocrinologist will review your history, explain likely treatment options, and estimate how long the process may take. This is also the time to ask direct timeline questions: Can baseline testing be done in my home country? Can stimulation monitoring be split between a local doctor and the U.S. clinic? How many days before retrieval should I arrive? Does the clinic recommend fresh transfer or frozen transfer? If we do PGT-A, how long do results take? Can medications be purchased abroad, or must they be ordered through a U.S. pharmacy?
Some clinics can schedule a consultation within a few days, while others have a waiting period of several weeks. If your goal is to begin treatment on a particular menstrual cycle, schedule the consultation as early as possible. IVF is cycle-dependent, and missing one required test or consent deadline can push treatment into the next month. International patients should also consider visa timing. A medical appointment letter from the clinic may help explain the purpose of travel, although visa approval depends on the rules of the relevant U.S. embassy or consulate.
Week 1 to Week 3: Diagnostic Testing and Medical Clearance
After the first consultation, the clinic will usually provide a checklist of required testing. This stage often takes one to three weeks, but it can take longer if your home country’s laboratory turnaround time is slow or if appointments are difficult to obtain. For the person providing eggs, common tests include AMH, day-2 or day-3 FSH and estradiol, LH, progesterone, prolactin, TSH, vitamin D in some cases, complete blood count, blood type, infectious disease screening, and a pelvic ultrasound to assess antral follicle count and ovarian anatomy. The physician may also request a uterine cavity evaluation such as saline infusion sonogram, hysteroscopy, or hysterosalpingogram to check for polyps, fibroids, scar tissue, congenital uterine anomalies, or blocked tubes.
For the sperm provider, testing usually includes semen analysis, infectious disease screening, and sometimes sperm DNA fragmentation testing, hormone testing, or urology evaluation if sperm count is low. If donor sperm is used, the clinic will guide you toward a sperm bank that meets U.S. tissue regulations. For couples using donor eggs, the testing focus shifts to the recipient’s uterine readiness and the sperm source. For patients using a gestational carrier, the carrier must complete medical screening, psychological evaluation, legal clearance, and infectious disease testing according to clinic and regulatory standards.
U.S. fertility clinics are careful about infectious disease screening because reproductive tissue handling is regulated. Required tests may include HIV, hepatitis B, hepatitis C, syphilis, HTLV in some circumstances, chlamydia, gonorrhea, and other labs depending on the clinic. These tests may need to be performed within a specific time window before egg retrieval or embryo transfer. If your testing is done outside the U.S., ask whether the clinic accepts overseas lab reports. Some clinics accept them if the report includes the patient’s full name, date of birth, collection date, test methodology, and reference ranges. Other clinics may require repeated testing in the U.S. because of regulatory or laboratory policy requirements.
This is also when genetic carrier screening may be discussed. Carrier screening checks whether an individual carries genetic variants that could be passed to a child. If both partners carry variants in the same recessive gene, there may be a higher risk of an affected child, and IVF with PGT-M may be considered. PGT-M is more complex than PGT-A and can add weeks or months because a custom genetic probe may need to be developed. Therefore, if you have a known family history of genetic disease, tell the clinic early. Waiting until stimulation begins can cause major delays.
Another part of medical clearance is reviewing general health. IVF is not only about eggs and sperm; it also involves anesthesia for egg retrieval, hormone medications, and pregnancy preparation. Patients may need clearance from a primary care doctor, cardiologist, endocrinologist, hematologist, or maternal-fetal medicine specialist if they have diabetes, hypertension, thyroid disease, autoimmune conditions, clotting disorders, heart disease, cancer history, severe obesity, or recurrent pregnancy loss. International travelers should not underestimate this step. A U.S. clinic may pause treatment if a condition is not adequately evaluated before pregnancy.
Week 2 to Week 4: Financial Planning, Consents, and Travel Strategy
While testing is underway, the clinic’s financial coordinator will usually provide a cost estimate. IVF in the U.S. can be expensive, and pricing varies widely by region and clinic. A base IVF cycle may not include medications, genetic testing, anesthesia, embryo freezing, embryo storage, donor services, outside monitoring, or frozen embryo transfer. Travelers should ask for a written estimate that separates each cost category. If paying by international wire transfer, confirm the clinic’s payment deadline and whether bank fees may delay posting. Some clinics require full payment before medications are started.
Consent forms are another important part of the timeline. IVF consent packets can be lengthy because they cover egg retrieval, anesthesia, insemination method, intracytoplasmic sperm injection, embryo culture, embryo freezing, embryo disposition, genetic testing, embryo transfer limits, multiple pregnancy risks, and what happens in the event of divorce, separation, death, or inability to contact the patients. Many clinics now allow electronic signatures, but some documents may need notarization or witness signatures. If you are outside the U.S., confirm whether electronic notarization is accepted or whether documents must be signed at a consulate, notary office, or in person at the clinic.
This is also the ideal time to create a travel strategy. If you are undergoing ovarian stimulation with your own eggs, ask whether you can start injections at home and travel to the U.S. around stimulation day 5 to day 8, or whether the clinic prefers you to be present from baseline onward. Some clinics are comfortable using outside monitoring from a local fertility center in your country. Others want all monitoring done in-house, particularly for patients expected to respond unpredictably. If outside monitoring is allowed, the U.S. clinic will usually specify exactly which tests are needed: transvaginal ultrasound measurements of follicles on each ovary, endometrial thickness, estradiol, LH, and progesterone. Results often must be sent the same day because medication doses may change quickly.
Flight planning should remain flexible. Egg retrieval is usually scheduled 34 to 36 hours after the trigger shot, and the trigger shot is based on follicle growth. No clinic can guarantee the retrieval date at the beginning of stimulation. It is safer to book changeable flights or plan a wider travel window. If you need to return home quickly after retrieval, ask the clinic how soon you can fly. Many patients can travel within one to three days after retrieval, but this depends on pain, bleeding risk, ovarian size, risk of ovarian hyperstimulation syndrome, and the physician’s recommendation.
For patients planning embryo transfer, the travel window can be more predictable, especially in a medicated frozen embryo transfer cycle. However, even transfer cycles can shift if the uterine lining is not thick enough, if progesterone timing needs adjustment, or if unexpected bleeding occurs. Patients should avoid scheduling major events immediately after transfer, not because bed rest is usually required, but because the emotional weight of the two-week wait can be significant.
Week 3 to Week 5: Cycle Synchronization and Medication Preparation
Many IVF cycles begin before injections start. Physicians often use birth control pills, estrogen priming, progesterone, or a natural-cycle start to synchronize follicle development and schedule the cycle. This pre-treatment phase may last one to three weeks. Travelers sometimes feel frustrated by this stage because it seems like “waiting,” but it can be important for improving scheduling and response. Birth control pills, for example, can help coordinate the start date so the patient can arrange flights more predictably. Estrogen priming may be used in some patients with diminished ovarian reserve to encourage a more even follicle cohort.
Medication ordering should be handled early. IVF medications may include FSH injections, LH or hMG injections, GnRH antagonist injections, trigger medication such as hCG or leuprolide acetate, progesterone, estrogen, antibiotics, pain medication, and other supportive medications. Some patients can obtain equivalent medications in their home country at lower cost, but they must confirm with the U.S. clinic that the formulation, dose, storage conditions, and timing are acceptable. Other patients order from a U.S. specialty pharmacy and either pick up medications after arrival or arrange delivery to a U.S. address. Many fertility medications require refrigeration or careful temperature control, so shipping internationally can be complicated.
Medication teaching is usually done by video, written instructions, or an in-person nurse visit. Patients should practice drawing up medication, changing needles, mixing powders, identifying injection sites, and safely disposing of sharps. This is especially important when traveling across time zones. The clinic will tell you whether injections should be taken at a specific local time or adjusted gradually. Never guess about timing; a missed antagonist dose or incorrectly timed trigger shot can compromise the cycle.
If a partner is providing sperm, the clinic may schedule sperm collection during the stimulation trip or freeze sperm in advance. Freezing sperm before the egg retrieval can reduce stress if the partner’s travel is uncertain, if there are visa risks, or if work obligations make timing difficult. For men with low sperm counts, a backup frozen sample may be especially valuable. If surgical sperm retrieval is needed, such as TESE or micro-TESE, this must be coordinated well ahead of time with a reproductive urologist.
Week 5 to Week 6: Baseline Appointment and Start of Ovarian Stimulation
The baseline appointment usually occurs at the beginning of the menstrual cycle or after pre-treatment suppression. It includes a transvaginal ultrasound and blood work. The goal is to confirm that the ovaries are quiet, there are no problematic cysts, hormone levels are appropriate, and the uterine lining is thin. If everything looks acceptable, the clinic instructs the patient to begin stimulation injections. If a cyst or elevated hormone level is present, the cycle may be delayed, adjusted, or occasionally canceled. This is one reason travelers should not purchase nonrefundable travel plans without discussing contingencies.
Ovarian stimulation typically lasts 8 to 12 days, although some patients stimulate for as few as 7 days or as many as 14 or more. During this time, injectable medications encourage multiple follicles to grow. The patient returns for monitoring every few days at first, then more frequently as follicles approach maturity. Monitoring evaluates follicle size, estradiol level, LH, progesterone, and sometimes endometrial thickness. Based on these results, the physician adjusts medication dosage and decides when to start antagonist medication to prevent premature ovulation.
For traveling patients doing early stimulation monitoring at home, this is the period when communication must be extremely efficient. Ultrasound images and lab values should be sent to the U.S. clinic promptly, taking into account time zone differences. It is not enough for a local doctor to say “everything looks fine.” The U.S. clinic needs exact follicle measurements, usually in millimeters, for each follicle above a certain size. Medication changes are based on details.
Patients often ask when they should arrive in the U.S. for retrieval. A common approach is to arrive by stimulation day 6 or 7, but this varies. Patients with a history of rapid response, high AMH, polycystic ovary syndrome, low ovarian reserve, prior premature ovulation, or complex protocols may be asked to arrive earlier. Once you are close to trigger, you should remain near the clinic. The final days of stimulation require close monitoring and rapid decision-making.
Week 6 to Week 7: Trigger Shot, Egg Retrieval, and Fertilization
When enough follicles reach mature size, the clinic schedules the trigger shot. The trigger is one of the most time-sensitive steps in IVF. It prepares the eggs for final maturation and must be administered at the exact time instructed, usually 34 to 36 hours before egg retrieval. Travelers should set multiple alarms and confirm the time zone. If the clinic says 10:00 p.m. Pacific Time and you are in California, that is different from 10:00 p.m. in another time zone. A timing error can lead to immature eggs, premature ovulation, or cycle failure.
Egg retrieval is a short outpatient procedure performed under sedation or anesthesia. The physician uses transvaginal ultrasound guidance to pass a needle into each follicle and aspirate follicular fluid. The embryology team examines the fluid to identify eggs. The procedure itself may take 15 to 30 minutes, but patients spend additional time in pre-operative preparation and recovery. You will need an adult escort to take you back to your hotel or accommodation because you cannot drive after anesthesia. Many clinics advise resting for the remainder of the day.
After retrieval, the clinic reports the number of eggs retrieved. Later, you may receive updates on how many eggs were mature and how many fertilized. Fertilization is commonly performed using ICSI, where a single sperm is injected into each mature egg, although conventional insemination may be used in some cases. ICSI is often recommended when sperm parameters are abnormal, when prior fertilization was poor, when PGT is planned, or when frozen eggs are used. Fertilization results are usually available the next day.
It is important to understand that the number of retrieved eggs is not the same as the number of embryos. Attrition occurs at each stage: not all follicles contain eggs, not all eggs are mature, not all mature eggs fertilize, not all fertilized eggs become blastocysts, and not all blastocysts are genetically normal. This is a normal part of IVF biology, not necessarily a sign that something went wrong. The physician can help interpret results based on age, ovarian reserve, sperm quality, stimulation response, and lab findings.
For travelers, the post-retrieval period requires some caution. Bloating, cramping, spotting, and fatigue are common. Severe pain, heavy bleeding, fever, shortness of breath, vomiting, rapid weight gain, or significant abdominal swelling should be reported immediately. Ovarian hyperstimulation syndrome is uncommon in severe form but can be serious. Patients at high risk may be advised to freeze all embryos and delay transfer. This is one reason fresh transfer is not always the safest or best choice.
Week 7: Embryo Culture and the Fresh Transfer Decision
After fertilization, embryos are cultured in the laboratory. Many U.S. clinics grow embryos to the blastocyst stage, usually day 5, day 6, and sometimes day 7 after fertilization. Blastocyst culture allows embryologists to identify embryos with better developmental potential and supports embryo biopsy if genetic testing is planned. During this week, the clinic may provide updates on embryo development, although update frequency differs among clinics. Some laboratories prefer fewer updates to avoid disturbing embryos and because early grading does not always predict final outcome.
If a fresh transfer is planned, the embryo transfer may occur on day 5 after retrieval, occasionally day 3 depending on clinic philosophy and patient circumstances. The patient remains in the U.S. from retrieval through transfer. Fresh transfer requires that the uterine lining and hormone environment are appropriate, that the patient is not at high risk for OHSS, and that there is at least one suitable embryo. If progesterone rises too early during stimulation or the ovaries respond too strongly, the physician may recommend freezing embryos and postponing transfer to a later cycle.
The transfer procedure itself is usually quick and does not require anesthesia. A thin catheter is passed through the cervix into the uterus, and the embryo is placed under ultrasound guidance. Patients often describe it as similar to a Pap test, although the emotional significance is much greater. Many clinics ask patients to have a comfortably full bladder because it improves ultrasound visualization and straightens the uterine angle. After transfer, brief rest may be recommended, but strict bed rest has not been shown to improve success and may even increase stress.
If no fresh transfer is planned, embryos suitable for freezing are vitrified. Vitrification is a rapid-freezing technique with high survival rates in experienced laboratories. If PGT-A is planned, a few cells are biopsied from the trophectoderm, the part of the blastocyst that later contributes to the placenta, and the embryo is frozen while the biopsy sample is sent to a genetics laboratory. Results often return in about one to three weeks, though timelines vary. Patients can usually return home after retrieval once medically cleared and wait for embryo results remotely.
Week 8 to Week 10: PGT-A Results and Frozen Embryo Transfer Planning
If you chose PGT-A, the waiting period after retrieval can feel long. PGT-A screens embryos for the correct number of chromosomes. Embryos reported as euploid have the expected chromosomal complement and generally have a higher chance of implantation and a lower risk of miscarriage than aneuploid embryos, especially as maternal age increases. However, PGT-A does not guarantee pregnancy or a healthy baby, and it does not test for every possible genetic or developmental condition. Mosaic or segmental results may require additional genetic counseling.
Once results are available, the physician or genetic counselor will review how many embryos are suitable for transfer. The clinic will also discuss embryo grading, sex disclosure if allowed by clinic policy and patient preference, and transfer priority. Many U.S. clinics strongly recommend single embryo transfer, particularly when a euploid embryo is available, because twin pregnancy increases risks for both the pregnant person and babies. These risks include preterm birth, gestational diabetes, hypertension, cesarean delivery, neonatal intensive care admission, and long-term complications related to prematurity.
The frozen embryo transfer cycle can begin with the next menstrual period or a later planned cycle. For travelers, the main question is whether to do a medicated cycle or a natural/modified natural cycle. In a medicated cycle, estrogen is used to build the uterine lining, then progesterone is added for a precise number of days before transfer. This schedule is predictable and often preferred for travel because the transfer date can be planned in advance once the lining is approved. In a natural or modified natural cycle, the clinic tracks ovulation and times the transfer based on the body’s own LH surge or a trigger shot. This may use fewer medications but can be less predictable for travel.
Before transfer, the clinic may require an updated uterine cavity evaluation if it has not already been done. Polyps, submucosal fibroids, adhesions, or fluid in the uterine cavity can reduce implantation chances. If an abnormality is found, hysteroscopic treatment may be needed, which can delay transfer by one or more cycles. For international patients, it is better to complete uterine evaluation early so problems are found before flights are booked.
Week 9 to Week 11: Preparing the Uterine Lining for Frozen Embryo Transfer
In a medicated frozen embryo transfer cycle, estrogen usually begins early in the menstrual cycle. Estrogen may be given as pills, patches, injections, or a combination, depending on the clinic’s protocol. After about 10 to 14 days, an ultrasound checks endometrial thickness and pattern, and blood work may evaluate estradiol and progesterone. Many clinics look for a lining of at least approximately 7 mm, although the ideal threshold varies and pregnancy can occur with thinner linings in some cases. The trilaminar or “three-line” appearance is often considered favorable before progesterone exposure.
If the lining is not ready, estrogen may be continued for several more days and the ultrasound repeated. This can shift the transfer date, so travelers should remain flexible. Once the lining is approved, progesterone begins. Progesterone timing is critical because it opens the window of implantation. For a day-5 blastocyst transfer, progesterone is typically administered for a specific number of hours or days before transfer. Clinics differ in how they count progesterone exposure, and patients must follow their own clinic’s instructions exactly.
Progesterone may be given as intramuscular injections, vaginal capsules, gels, suppositories, or a combination. Intramuscular progesterone is common in the U.S., but some patients find it uncomfortable. If you are traveling alone, ask in advance whether you can self-administer, whether a nurse visit can be arranged, or whether the clinic can recommend injection assistance. Bring enough medication for your travel period, plus extra in case of flight delays. Keep medications in original packaging with prescriptions or a doctor’s letter for airport security.
Some clinics perform the final lining check in the patient’s home country and ask the patient to arrive in the U.S. after progesterone has started. Others prefer the patient to be in the U.S. before progesterone initiation to reduce timing errors. If you are crossing several time zones, clarify exactly when to take progesterone during travel. A small timing mistake may not always be disastrous, but because transfer timing is so important, you should not make independent adjustments.
Week 10 to Week 12: Arrival for Embryo Transfer
Many patients arrive in the U.S. two to five days before a frozen embryo transfer, though some arrive earlier for monitoring. Arriving a few days early reduces the risk of flight delays interfering with the procedure and allows time for a final appointment, medication review, and rest. If you are traveling a long distance, jet lag can be intense. Try to adjust sleep gradually and avoid scheduling transfer on the same day as arrival unless the clinic specifically approves and the flight is short.
The embryo transfer day is carefully coordinated between the clinical team and embryology laboratory. The embryo is thawed before transfer, and survival rates are generally high with vitrified embryos in experienced labs. The physician may discuss the embryo selected for transfer and confirm identity checks. U.S. clinics use strict witnessing and labeling procedures to reduce the risk of mix-ups. Patients should also feel comfortable asking how identification is verified.
During the transfer, you may be asked to lie on an exam table while the physician places a speculum and cleans the cervix. An abdominal ultrasound may be used, so a full bladder may be requested. The embryologist loads the embryo into a catheter, and the physician gently passes it into the uterus. The embryo is deposited in a small volume of fluid. The catheter is checked afterward to confirm the embryo was released. The procedure usually takes only a few minutes once everything is ready.
After transfer, the clinic will provide instructions about activity, medications, travel, and pregnancy testing. Many patients can fly home one or two days after transfer, but recommendations vary. Some prefer to stay in the U.S. until the pregnancy blood test, usually 9 to 12 days after transfer, although this is not always medically necessary. The beta-hCG test can often be done at a qualified laboratory in the patient’s home country if results can be sent promptly to the clinic. If positive, repeat beta-hCG testing is usually done two days later to assess rise. An early ultrasound is typically scheduled around 6 to 7 weeks of pregnancy to confirm location, heartbeat, and number of gestational sacs.
A Detailed Week-by-Week Timeline
| Week | Main Activities | Travel Notes |
|---|---|---|
| Week 0 | Research clinics, request consultation, gather records, complete intake forms. | No travel usually needed; video consultation is often possible. |
| Week 1 | First physician consultation, initial treatment recommendation, testing checklist. | Ask exactly which tests can be done locally and which must be done in the U.S. |
| Week 2 | Blood work, ultrasound, semen analysis, infectious disease labs, uterine evaluation planning. | Use laboratories that can provide English reports if possible. |
| Week 3 | Results review, financial clearance, consent forms, medication planning. | Begin visa and flight planning, but keep reservations flexible. |
| Week 4 | Cycle synchronization with birth control, estrogen priming, or other protocol. | Confirm medication availability and storage requirements. |
| Week 5 | Baseline ultrasound and labs; start stimulation injections if cleared. | Some patients are still at home; others arrive in the U.S. for all monitoring. |
| Week 6 | Frequent monitoring, medication adjustments, antagonist medication, trigger shot. | Most retrieval patients should be near the clinic by mid-to-late stimulation. |
| Week 7 | Egg retrieval, fertilization, embryo culture, possible fresh transfer or embryo freezing. | Stay until medically cleared; avoid rigid departure dates immediately after retrieval. |
| Week 8 | PGT-A testing if chosen; recovery after retrieval; transfer planning begins. | Many patients return home during this waiting period. |
| Week 9 | PGT results review, frozen embryo transfer calendar, uterine preparation starts. | Local monitoring may reduce time in the U.S. |
| Week 10 | Lining check, estrogen adjustment if needed, progesterone start. | Travel may begin before or after progesterone depending on clinic policy. |
| Week 11 | Frozen embryo transfer, post-transfer instructions, beta-hCG scheduling. | Many patients stay 1 to 3 days after transfer; some stay until pregnancy test. |
| Week 12 | Pregnancy blood test and repeat beta-hCG if positive. | Testing can often be done at home with results sent to the U.S. clinic. |
How the Timeline Changes with Donor Eggs
Donor egg IVF can shorten some parts of the process and lengthen others. If frozen donor eggs are selected from an egg bank, treatment may move relatively quickly once the eggs are reserved and shipped or allocated. The recipient does not need ovarian stimulation or egg retrieval, so her physical time in the U.S. may be limited to uterine evaluation and embryo transfer. However, the sperm provider may need to travel for collection, or sperm may be frozen and shipped. Embryos are created by thawing donor eggs, fertilizing them, culturing embryos, and then either transferring or freezing them.
If a fresh egg donor is used, timing depends on donor matching, donor screening, legal agreements, and synchronization between the donor’s stimulation cycle and the recipient’s uterine preparation. Fresh donor cycles may take longer to arrange, especially if the patient wants a specific donor profile. U.S. donor programs typically include medical, genetic, psychological, and infectious disease screening. Legal contracts may be required, and intended parents should work with attorneys familiar with reproductive law in the relevant state.
For international patients, donor egg IVF is often attractive because it can reduce the need for a long stimulation trip. The recipient may prepare the lining at home under clinic guidance and travel for the transfer. Still, donor egg IVF is not a “one-week process” from first contact to transfer. Screening, donor selection, embryo creation, and legal steps can take several weeks or months. Patients should ask whether donor eggs are already available, whether embryos will be tested with PGT-A, and how many embryos are expected from a cohort of frozen donor eggs.
How the Timeline Changes with a Gestational Carrier
IVF with a gestational carrier is usually much longer than standard IVF because it includes medical, psychological, legal, and agency-related steps. The intended parents may first create embryos using their own eggs and sperm, donor eggs, donor sperm, or both. Embryos are typically frozen and often genetically tested. Separately, a gestational carrier must be matched, screened, and legally cleared before transfer. In the U.S., carrier arrangements are governed by state law, and requirements vary. Some states are considered more surrogacy-friendly than others, and legal guidance is essential.
The carrier’s medical screening includes uterine evaluation, pregnancy history review, infectious disease testing, general health assessment, and sometimes clearance from an obstetrician or maternal-fetal medicine specialist. Psychological evaluation is also standard. Legal contracts must be completed before the clinic can proceed with embryo transfer. Therefore, intended parents traveling to the U.S. for this pathway should think in months rather than weeks. While the embryo creation trip may resemble a standard retrieval trip, the transfer to a carrier occurs only after all carrier-related requirements are satisfied.
Recommended U.S. Fertility Clinics to Consider
The United States has many reputable fertility centers, and the right clinic depends on your diagnosis, location preference, budget, language needs, donor or surrogacy plans, and comfort with the medical team. The following list includes real fertility clinics that international and out-of-state patients may consider researching further. Always verify current physicians, addresses, lab services, success data, costs, and policies directly with the clinic before making decisions.
| Order | Clinic | Physician / Notes | Address |
|---|---|---|---|
| 1 | INCINTA Fertility Center | Dr. James P. Lin | 21545 Hawthorne Blvd / Pavilion B / Torrance CA 90503 |
| 2 | Reproductive Fertility Center | Southern California fertility clinic option for IVF consultation and treatment planning | 400 E Rincon St 1st Fl, Corona, CA 92879 |
| 3 | CCRM Fertility | National network known for IVF laboratory services and advanced reproductive care | 10290 RidgeGate Circle, Lone Tree, CO 80124 |
| 4 | RMA of New York | Large academic-affiliated fertility practice in New York City | 635 Madison Avenue, 10th Floor, New York, NY 10022 |
| 5 | Shady Grove Fertility | Large fertility network with multiple locations and donor/IVF services | 9601 Blackwell Road, 4th Floor, Rockville, MD 20850 |
How Many Days Should You Stay in the U.S.?
If you are doing an own-egg retrieval cycle, a practical minimum stay is often around 10 to 14 days if early monitoring can be done at home. This usually allows arrival around stimulation day 5 to 7, final monitoring, trigger, retrieval, and short recovery. If the clinic requires all monitoring in the U.S., plan for about 14 to 18 days before retrieval and recovery are complete. If you are also doing a fresh transfer, add about 5 days after retrieval, making the total stay closer to 16 to 22 days or sometimes longer.
For a frozen embryo transfer only, many patients can complete the U.S. portion in 5 to 10 days. A common plan is to complete early lining monitoring locally, start progesterone according to the U.S. clinic’s calendar, arrive several days before transfer, undergo transfer, and fly home after one or two days. Some patients stay until beta-hCG testing, which means remaining for about 9 to 12 days after transfer. This can be emotionally reassuring but is not always required medically.
For donor egg cycles, the recipient may need only the transfer trip if embryos are created in advance. If the partner needs to provide sperm in person, a separate sperm collection trip may be necessary, although frozen sperm can sometimes be shipped or banked. For gestational carrier cases, intended parents may travel for retrieval or sperm collection, but the carrier’s transfer schedule is separate and depends on legal clearance and medical preparation.
Always ask your clinic for the earliest and latest possible dates for each milestone. Instead of asking, “What day is my retrieval?” ask, “What is the expected retrieval window, and how often does it shift?” This helps you book accommodation and flights with realistic flexibility. Consider staying near the clinic during the final stimulation days and transfer period. Traffic in major U.S. cities can be unpredictable, and being late for an IVF appointment can create unnecessary stress.
Practical Travel Tips for International IVF Patients
First, organize your documents. Carry your passport, visa documentation if applicable, clinic appointment letter, medication prescriptions, medical records, lab reports, and emergency contact information. Keep digital copies in a secure cloud folder and printed copies in your carry-on bag. If you are bringing injectable medications, ask the clinic or pharmacy for a letter explaining that the medications and syringes are medically necessary. Airport security rules vary, and having documentation can prevent delays.
Second, plan medication storage. Some IVF medications must be refrigerated, while others should be kept at room temperature. Use an insulated medication travel case when needed, but avoid freezing medications by placing them directly against ice packs. Keep medications in your carry-on luggage, not checked baggage, because checked bags can be lost or exposed to extreme temperatures. Bring extra supplies, including alcohol swabs, needles, syringes, gauze, and a small sharps container or a safe temporary disposal option approved by your clinic.
Third, choose accommodation carefully. Staying close to the clinic reduces stress, especially when appointments are early in the morning. A hotel with a refrigerator may be important for medications. A small kitchen can help patients maintain a comfortable diet during stimulation. If you are staying after retrieval, choose a place where you can rest quietly. If you are traveling with children or family members, consider whether the environment will support recovery and emotional calm.
Fourth, understand communication expectations. U.S. clinics may communicate through patient portals, email, phone calls, or text systems. Make sure your phone works in the U.S. and that you can receive calls from the clinic. Check whether portal messages are monitored after hours. Know the emergency number for urgent symptoms. Because IVF decisions are time-sensitive, missed messages can cause confusion. If English is not your first language, ask whether translation support is available or whether you should bring a trusted interpreter.
Fifth, protect your emotional well-being. IVF travel can be isolating. You may be away from your normal support network, navigating a foreign healthcare system, and making high-stakes decisions while tired from medication and jet lag. Plan small routines that help you feel grounded: daily walks if approved, video calls with loved ones, simple meals, journaling, meditation, or counseling. Many clinics can refer patients to fertility counselors who understand the emotional complexity of treatment.
Common Reasons the Timeline Gets Delayed
Even with careful planning, IVF timelines can change. One common reason is incomplete testing. If infectious disease labs are missing, if a uterine cavity evaluation has not been done, or if semen analysis results are outdated, the clinic may not allow treatment to begin. Another reason is abnormal findings. A uterine polyp may need removal. A thyroid level may need correction. A cyst may require observation. A positive infectious disease screen may need confirmatory testing and special laboratory handling.
Ovarian response can also change the timeline. Some patients respond slowly and need extra stimulation days. Others respond too strongly and need a safer trigger strategy or a freeze-all plan. Occasionally, a cycle may be canceled if too few follicles grow, if ovulation occurs prematurely, or if hormone patterns suggest poor outcome. While cancellation is emotionally difficult, it may prevent unnecessary procedures and allow the physician to design a better protocol.
Embryo development can also affect plans. If no embryos reach the blastocyst stage by day 5, the lab may continue culture to day 6 or day 7. If PGT-A results are delayed, the transfer calendar may shift. If all embryos are aneuploid, there may be no transfer, and the next step may involve another retrieval, donor eggs, or a different treatment plan. This is one of the hardest parts of IVF: travel plans can be controlled, but embryo biology cannot.
Administrative delays are also possible. Consent forms may be incomplete, payment may not clear, donor sperm may not arrive on time, legal documents may be pending, or medication shipments may be delayed. International patients should start administrative tasks as early as possible. A good rule is to assume that every document takes longer than expected when it crosses borders, languages, banks, or legal systems.
Fresh Transfer vs. Frozen Transfer for Travelers
A fresh transfer can feel efficient because it combines retrieval and transfer in one trip. For some patients, this is medically reasonable and emotionally satisfying. However, fresh transfer is less common than it once was in many U.S. clinics, partly because freezing technology has improved and because frozen transfer allows the uterus to recover from stimulation. During ovarian stimulation, estrogen levels can rise far above natural-cycle levels, and progesterone may rise prematurely in some patients. These hormonal changes can affect endometrial receptivity.
Frozen transfer offers several advantages for travelers. It allows time for PGT-A results if testing is chosen. It reduces pressure to transfer an embryo in a cycle where the body may not be optimal. It gives the patient time to recover from retrieval and return home between steps. It also makes transfer scheduling more controlled, particularly with a medicated protocol. The downside is that it usually requires a second trip and extends the total calendar time.
The best choice is individualized. A young patient with good ovarian response, no PGT-A, low OHSS risk, and a receptive lining may be a good candidate for fresh transfer. A patient with high response, elevated progesterone, planned PGT-A, uterine concerns, or significant travel constraints may be better served by freezing embryos and transferring later. The decision should be made with the physician based on safety and success potential, not only convenience.
What Happens After You Go Home?
After embryo transfer, patients continue progesterone and often estrogen until pregnancy testing and, if pregnant, for several more weeks as instructed. Do not stop medications early unless your clinic tells you to. The beta-hCG blood test is usually scheduled about 9 to 12 days after a blastocyst transfer. Home pregnancy tests can be misleading if taken too early, and trigger shots from retrieval cycles can cause false positives if still present. A blood test is more reliable and provides a number that can be followed.
If the beta-hCG is positive, the clinic usually repeats it approximately 48 hours later. A rising level is reassuring, but the ultrasound is needed to confirm pregnancy location and viability. If the number is low or not rising appropriately, the clinic may monitor for biochemical pregnancy, early loss, or ectopic pregnancy. Even after IVF, ectopic pregnancy is possible, although uncommon. Seek urgent care if you have severe pain, shoulder pain, fainting, or heavy bleeding.
If pregnancy is confirmed, care gradually transitions from the fertility clinic to an obstetrician. International patients can usually continue pregnancy care in their home country once the fertility clinic has completed early monitoring. Ask for a clear medication stop schedule and copies of embryo transfer details, PGT results if applicable, early ultrasound reports, and estimated due date. If pregnancy does not occur, schedule a follow-up consultation with the U.S. physician to review embryo quality, transfer details, lining response, and next steps. A failed transfer does not always mean something was done wrong; implantation is biologically complex, and even high-quality embryos do not implant every time.
Sample Travel Scenarios
Scenario 1: Own eggs with PGT-A and frozen transfer. The patient completes video consultation in week 1, testing in weeks 1 to 3, starts birth control in week 4, begins stimulation in week 5, arrives in the U.S. on stimulation day 6, has retrieval in week 7, returns home two days later, receives PGT-A results in week 9, starts frozen transfer preparation in week 10, travels back to the U.S. in week 11, and completes transfer in week 12. Total calendar time is about 12 weeks, with roughly 18 to 24 total days in the U.S. across two trips.
Scenario 2: Own eggs with fresh transfer. The patient completes consultation and testing in the first three weeks, starts stimulation in week 5, arrives in the U.S. before baseline or by stimulation day 5, has retrieval in week 6 or 7, and undergoes fresh blastocyst transfer five days later. Total time after testing is complete may be 4 to 6 weeks, with a continuous U.S. stay around 16 to 22 days. This scenario is shorter overall but less flexible and not suitable for all patients.
Scenario 3: Frozen donor egg embryos and transfer only. The recipient completes consultation, uterine evaluation, and required labs in weeks 1 to 3. Donor eggs are selected and fertilized with partner or donor sperm. Embryos are cultured and frozen, with or without PGT-A. The recipient begins a medicated transfer cycle and travels to the U.S. shortly before transfer. Total calendar time may be 6 to 10 weeks if eggs and sperm are ready, with physical U.S. time as short as 5 to 10 days for the recipient. If donor matching or legal steps are needed, it can take longer.
Scenario 4: Embryos already frozen at a U.S. clinic. If embryos already exist and the patient only needs a frozen embryo transfer, the timeline may be as short as 3 to 6 weeks. The main steps are consultation or follow-up, updated labs, uterine cavity confirmation if needed, lining preparation, progesterone timing, and transfer. Travel time may be less than one week if monitoring is performed locally and the clinic is comfortable with that arrangement.
Questions to Ask Before Booking Flights
Before you book international travel, ask the clinic for a written calendar and clarify which dates are fixed versus estimated. Important questions include: What is my earliest possible retrieval date? What is my latest likely retrieval date? Can I complete baseline and early monitoring outside the U.S.? Which labs must be performed at your clinic? How quickly do you need outside monitoring results? What happens if my period starts earlier or later than expected? If I do PGT-A, how long do results usually take? Do you recommend fresh transfer or freeze-all in my case?
Also ask about practical details: Which airport is most convenient? How far is the clinic from typical hotel areas? Will I need an escort for retrieval? Can the clinic recommend nursing support for injections? Does the clinic provide medication teaching before I arrive? What should I do if medications are lost during travel? Is there an after-hours number? If I have complications after returning home, how will the U.S. clinic coordinate with my local doctor?
Financial questions are equally important. What is included in the quoted IVF package? Are monitoring visits included? Is anesthesia included? Is ICSI included? Are embryo biopsy, PGT laboratory fees, freezing, and storage billed separately? What is the cost of frozen embryo transfer? What happens financially if the cycle is canceled before retrieval? Are refunds or credits available? Do not rely on verbal estimates only; request written documentation.
Final Thoughts
So, how long does the IVF treatment process take when traveling to the U.S.? For most patients, the realistic answer is 6 to 12 weeks from first consultation to embryo transfer, with the possibility of a shorter timeline for transfer-only cases and a longer timeline for donor matching, PGT-M, gestational carrier arrangements, or unexpected medical findings. The time physically spent in the U.S. may range from less than a week for a straightforward frozen embryo transfer to three weeks or more for a full fresh IVF cycle. Many international patients divide treatment into two trips: one for egg retrieval and embryo creation, and another for frozen embryo transfer.
The most successful travel plans are built with flexibility. IVF is highly scheduled, but it is still guided by the body’s response. Follicles may grow faster or slower than predicted, the uterine lining may need extra time, genetic results may take longer, and travel delays can happen. Working with a clinic experienced in coordinating care for traveling patients can make the process smoother and less stressful.
Before committing to dates, complete as much testing as possible, clarify clinic policies, understand medication logistics, and ask for a personalized calendar. A week-by-week IVF timeline is a powerful planning tool, but it should be treated as a living document rather than a fixed itinerary. With careful preparation, clear communication, and realistic expectations, traveling to the United States for IVF can be organized in a way that protects both medical quality and personal peace of mind.
This article is for educational purposes only and does not replace medical advice. IVF protocols, travel recommendations, medication schedules, and legal requirements vary by clinic, state, diagnosis, and individual health history. Always consult a qualified reproductive endocrinologist and appropriate legal or immigration professionals before making treatment or travel decisions.